Balance in asthma between matrix metalloproteinases and their inhibitors.

[1]  J. Bousquet,et al.  Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects. , 1999, American journal of respiratory and critical care medicine.

[2]  S. Shapiro,et al.  Matrix metalloproteinases. Matrix degradation and more. , 1999, American journal of respiratory cell and molecular biology.

[3]  C. Reed.  The natural history of asthma in adults: the problem of irreversibility. , 1999, The Journal of allergy and clinical immunology.

[4]  D. Hartmann,et al.  Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. , 1999, American journal of respiratory and critical care medicine.

[5]  L. Boulet,et al.  Serum matrix metalloproteinase-9:Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. , 1999, American journal of respiratory and critical care medicine.

[6]  J. Bousquet,et al.  Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[7]  J. Bousquet,et al.  Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[8]  S. Isogai,et al.  Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. , 1998, The Journal of allergy and clinical immunology.

[9]  Hoshino,et al.  Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin‐like growth factor (IGF)‐I expression in bronchial asthma , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  J. Bousquet,et al.  Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. , 1997, American journal of respiratory cell and molecular biology.

[11]  A. Casalini,et al.  Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. , 1997, American journal of respiratory and critical care medicine.

[12]  K. Shirato,et al.  Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. , 1997, American journal of respiratory cell and molecular biology.

[13]  P. Venge,et al.  Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. , 1996, American journal of respiratory cell and molecular biology.

[14]  A. Foresi,et al.  Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma. , 1996, American journal of respiratory and critical care medicine.

[15]  G. Murphy,et al.  Matrix metalloproteinases and their inhibitors. , 1992, Acta orthopaedica Scandinavica. Supplementum.

[16]  R. Raghow,et al.  The role of extracellular matrix in postinflammatory wound healing and fibrosis , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  M. Calderón,et al.  Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. , 1994, American journal of respiratory and critical care medicine.

[18]  P. Jeffery,et al.  Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. , 1992, The American review of respiratory disease.

[19]  S. Shapiro,et al.  Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. , 1991, Journal of immunology.

[20]  A. Wardlaw,et al.  Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. , 1989, The American review of respiratory disease.

[21]  S. Holgate,et al.  SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS , 1989, The Lancet.

[22]  R. Stenling,et al.  Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. , 1988, The European respiratory journal.

[23]  H. Welgus,et al.  Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. , 1987, The Journal of clinical investigation.

[24]  A. Cats,et al.  HL-A 27 AND ANKYLOSING SPONDYLITIS , 1975, The Lancet.